130 results on '"Martino V."'
Search Results
2. C01/20 PREDICTORS OF CHRONIC HEPATITIS C (CHC) SEVERITY: RESULTS OF A MULTIVARIATE ANALYSIS OF 162 PATIENTS FOLLOWED IN A FRENCH PRIMARY REFERAL HOSPITAL
3. C01/021 HCV VIREMIA IS INCREASED IN HIV POSITIVE IV-DRUG USERS (IVDU)
4. Cost-effectiveness of elbasvir-grazoprevir association for treating hepatitis C virus genotype 1 infection in stage 4–5 chronic kidney disease patients in France
5. Impact of Cytomegalovirus infection on the outcome of patients with cirrhosis: a preliminary study
6. A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis
7. Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study
8. Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt
9. Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study
10. P0150 : Liver cirrhosis is independently associated with mortality in patients with bacterial endocarditis: Results of a case control multicenter study of 202 cases
11. P0132 : External validation of the CLIF-SOFA in cirrhotic patients admitted to intensive care units (ICUS): A meta-analysis
12. P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic
13. P0142 : Mortality risk factors in cirrhotic patients in Intensive Care Unit: A monocentric retrospective study at Besançon’s University Hospital from 2002 to 2014
14. LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program
15. P1246 : Abdominal ultrasonography guidance reduces the risk of complications and improves success rate after liver biopsy: Results of a meta-analysis comparing the use of ultrasound guidance to the “Blind method”
16. P0176 : Copeptin is an independent prognostic factor in liver cirrhosis
17. P0149 : Six-month mortality of cirrhotic patients who survived intensive care: A meta-analysis
18. G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort
19. O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study
20. P0821 : Are extended durations and/or ribavirin useful for genotype 1 (G1) cirrhotic patients who receive DAAs combination? A meta-analysis of randomized controlled trials (RCTS)
21. P0205 : Management of gastric varices: A french national survey
22. SAT-003 - Impact of Cytomegalovirus infection on the outcome of patients with cirrhosis: a preliminary study
23. THU-284 - Cost-effectiveness of elbasvir-grazoprevir association for treating hepatitis C virus genotype 1 infection in stage 4–5 chronic kidney disease patients in France
24. GS-001 - A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis
25. P455 BACTERIAL ENDOCARDITIS IN PATIENTS WITH CIRRHOSIS: A MULTICENTER RETROSPECTIVE STUDY OF 78 CASES
26. P449 PROGNOSTIC VALUE OF C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH CIRRHOSIS
27. O69 ALBUMIN INFUSION FOR BACTERIAL INFECTIONS OTHER THAN SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS: A MULTICENTER RANDOMIZED CONTROLLED STUDY (ALB-CIRINF STUDY)
28. PS018 - Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study
29. SAT-282 - Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme
30. FRI-483 - Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study
31. FRI-481 - Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt
32. 765 TWELVE-MONTHS ENTECAVIR LONGITUDINAL CHANGES IN LIVER FIBROSIS, ACTIVITY AS PER FibroTest-FibroMax AND LIVER STIFFNESS MEASUREMENTS IN CHRONIC HEPATITIS B. STEATOSIS IMPACT ON FIBROSIS REGRESSION
33. 923 EMERGENCE OF A NEW OPPORTUNISTIC INFECTION IN EUROPE: HEPATIC ALVEOLAR ECHINOCOCCOSIS. A FIFTY-CASE REPORT
34. 1156 USE OF EPOETIN BETA IN HEPATITIS C PATIENTS: SAFETY DATA FROM THE FRENCH TRIAL NEOS - INTERIM ANALYSIS AT SIX MONTHS
35. 712 PNPLA 3 RS738409 GG HOMOZYGOTE STATUS IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS
36. 463 ACHIEVEMENT OF RIBAVIRIN CUT-OFF BY MONITORING PLASMA CONCENTRATIONS BUT NOT HAEMOGLOBIN DROP IS PREDICTIVE OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C
37. 246 ASSESSMENT OF PAROXETINE IN THE PREVENTION OF DEPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C TREATED BY PEG-INTERFERON-RIBAVIRIN.: A DOUBLE-BLINDED, RANDOMIZED STUDY. ANRS HC18 PAROPEG
38. 1001 PRAGMATIC ASSESSMENT OF LIVER FIBROSIS DURING METHOTREXATE THERAPY: COMPARISON OF PATIENTS WITH PSORIASIS, RHEUMATOID ARTHRITIS OR CROHN'S DISEASE
39. 1091 DIAGNOSIS AND TREATMENT OF ALVEOLAR ECHINOCOCCOSIS OF THE LIVER IN IMMUNOCOMPROMISED PATIENTS
40. 429 IMPACT OF THE FAMILY SCREENING ON THE LONG-TERM PROGNOSIS OF WILSON'S DISEASE
41. 600 SHORTENED COURSE OF THERAPY FOR CHRONIC HEPATITIS C GENOTYPE 1 (G1) PATIENTS DEVELOPING RAPID VIROLOGICAL RESPONSE (RVR): META- ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (RCTS)
42. 274 THE CRP LEVEL IS A GOOD PREDICTOR OF MORTALITY INDEPENDENT OF PUGH OR MELD SCORES IN PATIENTS WITH END STAGE LIVER DISEASE (ESLD)
43. [554] VARIATION OF HEPATITIS C (HC) DETECTION RATE IN A FRENCH POPULATION ACCORDING TO SOCIO-ECONOMIC CONTEXT AND DISTANCE TO MEDICAL CARE
44. [651] USE OF HEMATOPOIETIC GROWTH FACTORS AS ADJUVANT THERAPY OF CHRONIC HEPATITIS C: A FRENCH NATIONAL SURVEY
45. 123 Impact of liver transplantation (LT) on alcohol consumption (AC) in patients with pugh B cirrhosis: A randomized study
46. 148 Impact of liver transplantation (LT) on survival of pugh B alcoholic cirrhotic patients: A multicenter randomized study
47. Is expansion of criteria for liver transplantation of patients with hepatocellular carcinoma possible? Lessons from a long-term follow-up cohort study assessing predictors of recurrence and mortality
48. Impact of hepatitis C-associated autoantibodies (AAbs) on the liver pathology and the response to antiviral therapy
49. Liver HCV RNA is correlated to Fas mRNA and to apoptosis in liver transplanted patients infected by hepatitis C
50. Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.